Bevin Fletcher
Contributing Editor/Science Writer

Bevin is a Contributing Editor/Science Writer for Bioscience Technology, where she focuses on the life sciences world, genomics, neurology, and biotechnology advances.  She graduated with a Bachelor’s degree in journalism and served as the Digital Editor of Bioscience Technology and wrote for Laboratory Equipment and LabOutlook and also previously worked as a reporter at The Deal.   

The human brain, the highly complex and still poorly understood epicenter of function, is hopefully going to become a little less mysterious.
Contributing Editor/Science Writer
|
8.3.2017
7:00am
Interim results from a 4-year PET scan study suggest that a significant number of patients being treated for Alzheimer’s disease may not actually have it at...
Contributing Editor/Science Writer
|
7.27.2017
7:30am
A team of scientists has identified two novel genes that impact a person’s risk for developing Alzheimer’s.
Contributing Editor/Science Writer
|
7.19.2017
8:00am
Researchers report new hope for treating bone loss and painful recurrent bone fractures associated with multiple myeloma bone cancer.
Contributing Editor/Science Writer
|
7.3.2017
8:00am
While still early, a new study reports that the disease process and motor symptoms of Huntington’s disease were reversed using CRISPR/Cas9 gene editing methods...
Contributing Editor/Science Writer
|
6.29.2017
10:46am
Advertisement
A new study tackles neuroscience from an evolutionary perspective, suggesting that humans’ past as hunter-gatherers laid the foundation for why our brains...
Contributing Editor/Science Writer
|
6.28.2017
10:57am
Scientists restored serotonin to normal levels in mouse models of autism, and improved social behaviors tied to the condition after administering the FDA-...
Contributing Editor/Science Writer
|
6.27.2017
10:36am
There is an urgent need to ramp up the number of therapies entering the Alzheimer’s disease pipeline, according the Cleveland Clinic’s second annual analysis...
Contributing Editor/Science Writer
|
6.26.2017
10:57am
A new antibody has been developed that targets blood cancer in two ways, by killing the cancer cells directly and by pushing them out of the fostering bone...
Contributing Editor/Science Writer
|
6.23.2017
11:01am
Resveratrol, a powerful antioxidant found in the skin and seeds of grapes has been touted for a variety of health benefits. Now, a new study from Penn State...
Contributing Editor/Science Writer
|
6.21.2017
10:59am
Liquid biopsies for various cancers are being developed as non-invasive early detection methods that could save lives and offer a more personalized approach to...
Contributing Editor/Science Writer
|
6.20.2017
10:56am
A new study has detailed microscopic brain changes following a concussion, and outlined a probable mechanism for swelling that could lead to better treatments...
Contributing Editor/Science Writer
|
6.16.2017
10:45am
When people hear the word telomere they typically think of length and longevity. 3D Signatures, a Toronto-based, publicly funded company is taking a different...
Contributing Editor/Science Writer
|
6.15.2017
11:18am
Advertisement
In a prospective study, researchers used metabolomics to identify a potential new biomarker linked to the risk of developing dementia and Alzheimer’s.
Contributing Editor/Science Writer
|
6.15.2017
11:15am
Researchers are repurposing a decades-old malaria drug to target a genetic mutation in patients with the inherited form of amyotrophic lateral sclerosis (ALS).
Contributing Editor/Science Writer
|
6.14.2017
10:00am
Sitting down for dinner? Extra red onions, please. This may become a new mantra for those wanting to stave off cancer, according to a new study from Canadian...
Contributing Editor/Science Writer
|
6.13.2017
10:15am
UCLA researchers developed a compound, known as a molecular tweezer, which disrupts the formation of toxic protein clumps and improved balance and movement in...
Contributing Editor/Science Writer
|
6.13.2017
10:14am
A new blood-brain barrier model made of self-assembling spheroids displays more accurate and reproducible features and functions than other current models,...
Contributing Editor/Science Writer
|
6.9.2017
11:17am
Many people are familiar with the body’s 24-hour biological clock that follows a circadian rhythm and regulates things like sleep and wake cycles. However less...
Contributing Editor/Science Writer
|
6.8.2017
10:34am
A new study is providing more clues to the origin and progression of the most frequent tumors including those of colon, lung and breast cancer.
Contributing Editor/Science Writer
|
6.8.2017
10:32am
About 60 volunteers went on 2.5 mile hikes through the British countryside, each wearing a sock on the outside of one shoe, to help a group of UK researchers...
Contributing Editor/Science Writer
|
6.6.2017
10:37am
Advertisement
Three chemists from the University at Albany are joining forces to lay the groundwork for visualizing and understanding how RNA and protein molecules interact...
Contributing Editor/Science Writer
|
6.2.2017
11:47am
Researchers, reporting in Oncotarget, described efficacy results from the first 17 patients in a Phase 2 trial for the treatment of adult recurrent...
Contributing Editor/Science Writer
|
6.1.2017
10:31am
Australia-based regenerative medicine and stem cell company Cynata Therapeutics Ltd., announced that the first patient has been dosed with the company’s...
Contributing Editor/Science Writer
|
5.25.2017
10:40am
San Diego-based 3D bioprinting company Organovo, presented new preclinical data on its 3D bioprinted human liver tissues for the treatment of inborn errors of...
Contributing Editor/Science Writer
|
5.23.2017
10:14am
Researchers from Cedars Sinai Medical Center have developed a new technique that, if successful in humans, could replace traditional bone grafts for mending...
Contributing Editor/Science Writer
|
5.19.2017
10:12am
Researchers from the Gladstone Institutes have discovered newly-developed cancer drugs may also provide a treatment option for heart failure patients.
Contributing Editor/Science Writer
|
5.17.2017
2:04pm
South Korean scientists recently published data showing that novel, cell-penetrating antibodies targeting the RAS gene family, produce anti-tumor activity in...
Contributing Editor/Science Writer
|
5.16.2017
10:07am
The Food and Drug Administration has approved the drug Radicava, also known as edaravone, for the treatment for amyotrophic lateral sclerosis (ALS). This is...
Contributing Editor/Science Writer
|
5.15.2017
10:24am
Fruit flies typically depend on yeast as a main protein source, but have a natural tendency to seek out a quick fix of sugar. New research has found a small...
Contributing Editor/Science Writer
|
5.12.2017
10:39am
New safety risks were identified for nearly one out of every three drugs approved by the Food and Drug Administration (FDA) in the years following approval,...
Contributing Editor/Science Writer
|
5.11.2017
11:02am
A gene mutation may speed up memory loss and cognitive decline in people at risk for Alzheimer’s disease, a new study found.
Contributing Editor/Science Writer
|
5.10.2017
10:35am
In preclinical studies, researchers found adoptive T cell therapy was more effective against melanoma when combined with common platelet-inhibitors, such as...
Contributing Editor/Science Writer
|
5.9.2017
10:11am
Helen Torley, M.B, Ch.B., came across an interesting statistic last year. Out of the 44 publicly traded biotech companies in the thriving life science hub of...
Contributing Editor/Science Writer
|
5.8.2017
11:46am
Brazilian scientists have performed early preclinical studies that suggest a low dose of the antibiotic doxycycline may offer a potential treatment against...
Contributing Editor/Science Writer
|
5.5.2017
10:57am
Researchers have developed a new crawling assay using mutated fruit fly larvae and an open-source application called LarvaTrack that they say provide a quick,...
Contributing Editor/Science Writer
|
5.3.2017
10:23am
A novel hydrogel antibacterial wound covering could help in the fight against antimicrobial resistance by preventing thousands of people each year from...
Contributing Editor/Science Writer
|
5.2.2017
10:07am
Simone T. Sredni, M.D., Ph.D., associate professor of pediatric neurosurgery has been working in pediatric brain cancer research for about 15 years. In an...
Contributing Editor/Science Writer
|
5.1.2017
11:01am
Stanford neuroscientists have created a 3D model to investigate the developing forebrain, and were able to observe —and correct—faulty cell migration due to an...
Contributing Editor/Science Writer
|
4.28.2017
10:24am